Selenium and Metabolic Disorders: An Emphasis on Type 2 Diabetes Risk.

Nutrients · 2016 · PMC4772044 · PMID 26861388

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

The Selenium and Vitamin E Cancer Prevention Trial (SELECT), testing the effects of selenomethionine (SMet, 200 μg/day) and/or Vitamin E in preventing prostate cancer was curtailed as it became apparent Se supplementation did not appear beneficial in the prevention of prostate cancer, and a nonsignificant trend towards T2D in the experimental group was reported [ 13 , 14 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.